Shen C - Search Results

1

Pathologic upstaging in resected pancreatic adenocarcinoma: Risk factors and impact on survival.

Olecki EJ, Stahl KA, Torres MB, Peng JS, Shen C, Dixon MEB, Gusani NJ. Olecki EJ, et al. Among authors: shen c. J Surg Oncol. 2021 Jul;124(1):79-87. doi: 10.1002/jso.26481. Epub 2021 Apr 9. J Surg Oncol. 2021. PMID: 33836095

2

Clinical, pathological, and demographic factors associated with development of recurrences after surgical resection in elderly patients with neuroendocrine tumors.

Shen C, Dasari A, Chu Y, Halperin DM, Zhou S, Xu Y, Shih YT, Yao JC. Shen C, et al. Ann Oncol. 2017 Jul 1;28(7):1582-1589. doi: 10.1093/annonc/mdx164. Ann Oncol. 2017. PMID: 28444105 Free PMC article.

3

Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States.

Dasari A, Shen C, Halperin D, Zhao B, Zhou S, Xu Y, Shih T, Yao JC. Dasari A, et al. Among authors: shen c. JAMA Oncol. 2017 Oct 1;3(10):1335-1342. doi: 10.1001/jamaoncol.2017.0589. JAMA Oncol. 2017. PMID: 28448665 Free PMC article.

4

Undertreatment of Pancreatic Cancer: Role of Surgical Pathology.

Olecki EJ, Stahl K, Peng JS, Dixon M, Gusani NJ, Shen C. Olecki EJ, et al. Among authors: shen c. Ann Surg Oncol. 2021 Mar;28(3):1581-1592. doi: 10.1245/s10434-020-09043-y. Epub 2020 Aug 26. Ann Surg Oncol. 2021. PMID: 32851518

5

ASO Author Reflections: Undertreatment of Pancreatic Cancer After Resection: Don't Get Fooled by Favorable Final Pathology.

Olecki E, Gusani N, Shen C. Olecki E, et al. Among authors: shen c. Ann Surg Oncol. 2021 Mar;28(3):1593-1594. doi: 10.1245/s10434-020-09079-0. Epub 2020 Aug 28. Ann Surg Oncol. 2021. PMID: 32860172 No abstract available.

6

ASO Author Reflections: Surgery Offers Survival Advantage in Treatment-Responsive Metastatic Breast Cancer.

Stahl K, Dodge D, Shen C. Stahl K, et al. Among authors: shen c. Ann Surg Oncol. 2021 May;28(5):2659. doi: 10.1245/s10434-020-09286-9. Epub 2020 Oct 28. Ann Surg Oncol. 2021. PMID: 33118121 No abstract available.

7

Benefits of Surgical Treatment of Stage IV Breast Cancer for Patients With Known Hormone Receptor and HER2 Status.

Stahl K, Wong W, Dodge D, Brooks A, McLaughlin C, Olecki E, Lewcun J, Newport K, Vasekar M, Shen C. Stahl K, et al. Among authors: shen c. Ann Surg Oncol. 2021 May;28(5):2646-2658. doi: 10.1245/s10434-020-09244-5. Epub 2020 Oct 30. Ann Surg Oncol. 2021. PMID: 33128117

8

Adjuvant Chemotherapy After Neoadjuvant Chemotherapy for Pancreatic Cancer is Associated with Improved Survival for Patients with Low-Risk Pathology.

Olecki EJ, Stahl KA, Torres MB, Peng JS, Dixon M, Shen C, Gusani NJ. Olecki EJ, et al. Among authors: shen c. Ann Surg Oncol. 2021 Jun;28(6):3111-3122. doi: 10.1245/s10434-020-09546-8. Epub 2021 Jan 31. Ann Surg Oncol. 2021. PMID: 33521899

9

Gastric Cancer Treatments and Survival Trends in the United States.

Stahl KA, Olecki EJ, Dixon ME, Peng JS, Torres MB, Gusani NJ, Shen C. Stahl KA, et al. Among authors: shen c. Curr Oncol. 2020 Dec 24;28(1):138-151. doi: 10.3390/curroncol28010017. Curr Oncol. 2020. PMID: 33704182 Free PMC article.

10

Survival Benefit of Guideline-Concordant Postoperative Radiation for Local Merkel Cell Carcinoma.

Wong WG, Stahl K, Olecki EJ, Holguin RP, Pameijer C, Shen C. Wong WG, et al. Among authors: shen c. J Surg Res. 2021 Oct;266:168-179. doi: 10.1016/j.jss.2021.03.062. Epub 2021 May 17. J Surg Res. 2021. PMID: 34015514

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,026 results

Search Page

Filters